Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E van Houtte

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Blood|March 15, 1992
Disturbed platelet aggregation to collagen associated with an antibody against an 85- to 90-Kd platelet glycoprotein in a patient with prolonged bleeding timeH Deckmyn, E Van Houtte, J Vermylen
Biochemical Pharmacology|September 15, 1983
Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatromH Deckmyn, E Van Houtte, M Verstraete, et al.
Blood|September 15, 1994
Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIaH Deckmyn, J Zhang, E Van Houtte, et al.
Thrombosis and Haemostasis|December 29, 1984
Thromboxane synthase inhibition combined with thromboxane receptor blockade: a step forward in antithrombotic strategy?P Gresele, E Van Houtte, J Arnout, et al.
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|July 24, 2001
HACCP (Hazard Analysis and Critical Control Points) to guarantee safe water reuse and drinking water production--a case studyT Dewettinck, E Van Houtte, D Geenens, et al.
Journal of the Neurological Sciences|November 25, 2000
Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neuronsL Van Den Bosch, W Vandenberghe, H Klaassen, et al.
Lancet (London, England)|February 21, 1981
Prostacyclin and pre-eclampsiaL O Carreras, G Defreyn, E van Houtte, et al.
Thrombosis and Haemostasis|July 6, 1992
Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivoD E Vaughan, P J Declerck, E Van Houtte, et al.
Thrombosis and Haemostasis|February 28, 1989
Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis modelD Spriggs, H K Gold, Y Hashimoto, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Blood|March 15, 1992
Disturbed platelet aggregation to collagen associated with an antibody against an 85- to 90-Kd platelet glycoprotein in a patient with prolonged bleeding timeH Deckmyn, E Van Houtte, J Vermylen
Biochemical Pharmacology|September 15, 1983
Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatromH Deckmyn, E Van Houtte, M Verstraete, et al.
Blood|September 15, 1994
Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIaH Deckmyn, J Zhang, E Van Houtte, et al.
Thrombosis and Haemostasis|December 29, 1984
Thromboxane synthase inhibition combined with thromboxane receptor blockade: a step forward in antithrombotic strategy?P Gresele, E Van Houtte, J Arnout, et al.
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|July 24, 2001
HACCP (Hazard Analysis and Critical Control Points) to guarantee safe water reuse and drinking water production--a case studyT Dewettinck, E Van Houtte, D Geenens, et al.
Journal of the Neurological Sciences|November 25, 2000
Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neuronsL Van Den Bosch, W Vandenberghe, H Klaassen, et al.
Lancet (London, England)|February 21, 1981
Prostacyclin and pre-eclampsiaL O Carreras, G Defreyn, E van Houtte, et al.
Thrombosis and Haemostasis|July 6, 1992
Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivoD E Vaughan, P J Declerck, E Van Houtte, et al.
Thrombosis and Haemostasis|February 28, 1989
Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis modelD Spriggs, H K Gold, Y Hashimoto, et al.
Pageof 2